FREZZATO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.459
EU - Europa 874
AS - Asia 831
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
AF - Africa 2
Totale 7.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.453
CN - Cina 504
IT - Italia 313
SG - Singapore 263
FI - Finlandia 141
SE - Svezia 124
DE - Germania 107
GB - Regno Unito 75
FR - Francia 52
IN - India 29
VN - Vietnam 25
UA - Ucraina 17
NL - Olanda 15
RU - Federazione Russa 12
CA - Canada 6
IE - Irlanda 5
AT - Austria 4
AU - Australia 4
EU - Europa 4
HK - Hong Kong 3
JP - Giappone 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LU - Lussemburgo 1
NG - Nigeria 1
PL - Polonia 1
PY - Paraguay 1
TR - Turchia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 7.180
Salva come PNG Salva come JPEG
Città #
Fairfield 848
Chandler 518
Woodbridge 486
Houston 458
Ashburn 398
Ann Arbor 360
Cambridge 344
Seattle 343
Wilmington 275
Singapore 202
Boardman 139
Padova 131
Beijing 102
Santa Clara 102
Jacksonville 91
Helsinki 89
Princeton 79
San Diego 78
Des Moines 68
Medford 65
Nanjing 56
Guangzhou 49
New York 49
Jinan 35
Dong Ket 24
Shenyang 23
Dallas 20
Shanghai 20
London 18
Redwood City 17
Roxbury 16
Changsha 15
Hebei 13
Jiaxing 13
Nanchang 13
Pune 12
Falls Church 11
Haikou 11
Chicago 10
Tianjin 10
Hangzhou 9
Milan 9
Paris 9
Los Angeles 8
Amsterdam 7
Hefei 7
Norwalk 7
Phoenix 7
Taizhou 7
Zhengzhou 7
Cagliari 6
Kilburn 6
Aprilia 5
Chieti 5
Dublin 5
Fuzhou 5
Ogden 5
Taiyuan 5
Turin 5
Washington 5
Bologna 4
Frankfurt am Main 4
Munich 4
Nürnberg 4
Pignone 4
Rome 4
San Francisco 4
Caprino Veronese 3
Detroit 3
Florence 3
Grisignano di Zocco 3
Hong Kong 3
Hounslow 3
Kunming 3
Las Vegas 3
Melbourne 3
Monza 3
Ningbo 3
North York 3
Redmond 3
Salsomaggiore Terme 3
Sassari 3
Tappahannock 3
Tver 3
Vienna 3
Wuhan 3
Acton 2
Afragola 2
Arezzo 2
Baotou 2
Belvedere Spinello 2
Bergamo 2
Binasco 2
Borås 2
Castegnato 2
Doesburg 2
Indiana 2
Isola della Scala 2
Istrana 2
Kochi 2
Totale 5.853
Salva come PNG Salva come JPEG
Nome #
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL 201
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 173
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells 170
Role of miR-15a/miR-16-1 and TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia 155
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 154
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 154
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 153
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 148
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia 140
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 138
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 134
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. 133
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 133
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. 132
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 131
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 130
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 130
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 129
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 124
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 120
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes 118
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment 117
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 117
Endogenous reactive oxygen species content and modulation of tyrosine phosphorylation during sperm capacitation. 116
Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia 115
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 114
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia 114
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes 111
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 110
Role of hematopoietic-specific protein 1 (HS1) in apoptosis in B-chronic lymphocytic leukemia. 108
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 107
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 107
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. 107
High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals 103
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 103
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 103
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C 101
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape 100
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 98
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 95
Hexokinase 2 displacement from mitochondria‐associated membranes prompts Ca 2+ ‐dependent death of cancer cells 95
Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma 94
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 94
Targeting Brutons Tyrosine Kinase in Chronic Lymphocytic Leukemia at the Crossroad between Intrinsic and Extrinsic Pro-survival Signals 91
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 91
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 85
Inhibition of a Mitochondrial Potassium Channel as a New Therapeutic Strategy for Chronic Lymphocytic Leukemia 80
S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis. 78
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells 76
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model 70
Coinvolgimento della proteina HS1 nella sopravvivenza dei linfociti B neoplastici di pazienti con leucemia linfatica cronica 70
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 68
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment 68
Phosphorylation of PP2A by Lyn is a key phenomenon in the cancer phenotype of B-CLL 67
Biophysical Characterization of the Potassium Channel Kv1.3 in B Cells from Patients Affected by Chronic Lymphocytic Leukemia 67
Hematopoietic lineage cell specific protein 1 (HS1) is a new prognostic marker and is involved in cell growth of B-cell chronic lymphocytic leukemia 66
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 66
Cyclosporin A and dexamethasone induce apoptosis in malignant cells of patients with B-chronic lymphocytic leukemia 66
A comparision between isotype control and ratio metric method to detect ZAP70 expression in B-cell chronic lymphocytic leukemia (B-CLL) 63
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 63
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 60
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 58
Le HDL desensibilizzano i sinoviociti al rilascio di MCP-1 dai granuli secretori citoplasmatici indotto da cristalli di urato. 55
Leukemic cell from B-CLL patients display heterogeneous response to the anti-apoptotic effect of mesenchymal stromal cells 54
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 54
Lyn tyrosine kinase accumulates as a protein-complex in the cytosol of leukemic B-CLL cells 50
DOWNREGULATION OF SURFACE SQUAMOUS CELL CARCINOMA ANTIGEN EXPRESSION AND CD27+ MOLECULE ON B LYMPHOCYTES IN PATIENTS WITH CHRONIC HEPATITIS C 49
Lyn tyrosine kinase is abnormally expressed in chronic lymphocytic leukemia tumor B cells and contributes to defective apoptosis 47
ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E CELLULE B DELLA MEMORIA IN CORSO DI INFEZIONE DA VIRUS DELL’EPATITE C 44
APOPTOTIC EFFECT OF CYCLOSPORIN A AND DEXAMETHASONE IN MALIGNANT CELLS OF PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA 43
CYCLOSPORIN A AND DEXAMETHASONE INDUCE APOPTOSIS IN MALIGNANT CELLS OF PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA 39
Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation 28
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 26
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia 23
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation 22
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? 22
How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia 18
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence 14
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy 13
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course 13
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens 10
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation 8
Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia 6
null 5
p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB 4
Totale 7.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.278
article - articoli 26.375
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.012 0 0 0 0 0 97 130 172 150 244 148 71
2020/20211.164 88 79 64 148 47 48 41 103 146 178 145 77
2021/20221.114 58 108 112 109 71 66 42 112 86 28 90 232
2022/20231.031 171 121 27 141 157 111 13 74 120 15 62 19
2023/2024632 27 73 66 47 65 106 30 38 17 57 52 54
2024/2025687 5 163 125 91 230 73 0 0 0 0 0 0
Totale 7.329